These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21829606)

  • 1. p53 Interacts with RNA polymerase II through its core domain and impairs Pol II processivity in vivo.
    Kim S; Balakrishnan SK; Gross DS
    PLoS One; 2011; 6(8):e22183. PubMed ID: 21829606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor p53 associates with gene coding regions and co-traverses with elongating RNA polymerase II in an in vivo model.
    Balakrishnan SK; Gross DS
    Oncogene; 2008 Apr; 27(19):2661-72. PubMed ID: 18026140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the p53/RNA polymerase II assembly.
    Liou SH; Singh SK; Singer RH; Coleman RA; Liu WL
    Commun Biol; 2021 Mar; 4(1):397. PubMed ID: 33767390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural visualization of the p53/RNA polymerase II assembly.
    Singh SK; Qiao Z; Song L; Jani V; Rice W; Eng E; Coleman RA; Liu WL
    Genes Dev; 2016 Nov; 30(22):2527-2537. PubMed ID: 27920087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
    Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
    Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation and specific DNA improved the incorporation ability of p53 into functional condensates.
    Chen Q; Wu Y; Dai Z; Zhang Z; Yang X
    Int J Biol Macromol; 2023 Mar; 230():123221. PubMed ID: 36634798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separable functions of the fission yeast Spt5 carboxyl-terminal domain (CTD) in capping enzyme binding and transcription elongation overlap with those of the RNA polymerase II CTD.
    Schneider S; Pei Y; Shuman S; Schwer B
    Mol Cell Biol; 2010 May; 30(10):2353-64. PubMed ID: 20231361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 activates transcription by directing structural shifts in Mediator.
    Meyer KD; Lin SC; Bernecky C; Gao Y; Taatjes DJ
    Nat Struct Mol Biol; 2010 Jun; 17(6):753-60. PubMed ID: 20453859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 represses the transcription of snRNA genes by preventing the formation of little elongation complex.
    Anwar D; Takahashi H; Watanabe M; Suzuki M; Fukuda S; Hatakeyama S
    Biochim Biophys Acta; 2016 Aug; 1859(8):975-82. PubMed ID: 27268141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new era of studying p53-mediated transcription activation.
    Liu WL; Coleman RA; Singh SK
    Transcription; 2018; 9(2):102-107. PubMed ID: 28795863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ESS1 prolyl isomerase and its suppressor BYE1 interact with RNA pol II to inhibit transcription elongation in Saccharomyces cerevisiae.
    Wu X; Rossettini A; Hanes SD
    Genetics; 2003 Dec; 165(4):1687-702. PubMed ID: 14704159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolutionarily conserved Pol II flap loop contributes to proper transcription termination on short yeast genes.
    Pearson E; Moore C
    Cell Rep; 2014 Nov; 9(3):821-8. PubMed ID: 25437538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain.
    Parada CA; Roeder RG
    Nature; 1996 Nov; 384(6607):375-8. PubMed ID: 8934526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A yeast heterogeneous nuclear ribonucleoprotein complex associated with RNA polymerase II.
    Conrad NK; Wilson SM; Steinmetz EJ; Patturajan M; Brow DA; Swanson MS; Corden JL
    Genetics; 2000 Feb; 154(2):557-71. PubMed ID: 10655211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separate domains of fission yeast Cdk9 (P-TEFb) are required for capping enzyme recruitment and primed (Ser7-phosphorylated) Rpb1 carboxyl-terminal domain substrate recognition.
    St Amour CV; Sansó M; Bösken CA; Lee KM; Larochelle S; Zhang C; Shokat KM; Geyer M; Fisher RP
    Mol Cell Biol; 2012 Jul; 32(13):2372-83. PubMed ID: 22508988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA polymerase I (Pol I) passage through nucleosomes depends on Pol I subunits binding its lobe structure.
    Merkl PE; Pilsl M; Fremter T; Schwank K; Engel C; Längst G; Milkereit P; Griesenbeck J; Tschochner H
    J Biol Chem; 2020 Apr; 295(15):4782-4795. PubMed ID: 32060094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical interaction and functional antagonism between the RNA polymerase II elongation factor ELL and p53.
    Shinobu N; Maeda T; Aso T; Ito T; Kondo T; Koike K; Hatakeyama M
    J Biol Chem; 1999 Jun; 274(24):17003-10. PubMed ID: 10358050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinction and relationship between elongation rate and processivity of RNA polymerase II in vivo.
    Mason PB; Struhl K
    Mol Cell; 2005 Mar; 17(6):831-40. PubMed ID: 15780939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Mediator in regulating Pol II elongation and nucleosome displacement in Saccharomyces cerevisiae.
    Kremer SB; Kim S; Jeon JO; Moustafa YW; Chen A; Zhao J; Gross DS
    Genetics; 2012 May; 191(1):95-106. PubMed ID: 22377631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The conserved foot domain of RNA pol II associates with proteins involved in transcriptional initiation and/or early elongation.
    García-López MC; Pelechano V; Mirón-García MC; Garrido-Godino AI; García A; Calvo O; Werner M; Pérez-Ortín JE; Navarro F
    Genetics; 2011 Dec; 189(4):1235-48. PubMed ID: 21954159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.